21. September 2018
Three-dimensional (3D) printing was discovered in the 1980s, and many industries have embraced it, but the pharmaceutical industry is slow or reluctant to adopt it. Spiritam® is the first and only 3D-printed drug product approved by FDA in 2015. Since then, the FDA has not approved any 3D-printed drug product due to technical and regulatory issues. The 3D printing process cannot compete with well-established and understood conventional processes for making solid dosage forms. However,...
09. October 2017
Tablets with HPMC/CH are the most suitable for vaginal controlled release of TFV.
HPMC/CH tablets show vaginal mucoadhesion time according to the TFV release time. A higher proportion of CH than HPMC has a moderate swelling and faster erosion